Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J FitzGerald

Showing results (91-100 of 271) with videos related to

Pageof 28
Sort By:
Journal of Virology|September 1, 1984
Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugateP Seth, D J Fitzgerald, M C Willingham, et al.
Cell|February 1, 1983
Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosisD J FitzGerald, R Padmanabhan, I Pastan, et al.
British Medical Journal (Clinical Research Ed.)|May 14, 1983
Accuracy of indirect blood pressure measurement in the elderlyW G O'Callaghan, D J Fitzgerald, K O'Malley, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Selective cyclooxygenase-2 inhibition by nimesulide in manL Cullen, L Kelly, S O Connor, et al.
Cancer Research|July 15, 1988
Enhancement of the activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell linesR Pirker, D J FitzGerald, M C Willingham, et al.
The Journal of Biological Chemistry|November 25, 1990
Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosolM Ogata, V K Chaudhary, I Pastan, et al.
The Journal of Biological Chemistry|October 15, 1993
Mechanism of action of Pseudomonas exotoxin. Identification of a rate-limiting stepA G Zdanovsky, M Chiron, I Pastan, et al.
Circulation|August 1, 1993
Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesisR M Keimowitz, G Pulvermacher, G Mayo, et al.
Perfusion|August 6, 2009
The relationship between heparin level and activated clotting time in the adult cardiac surgery populationD J Fitzgerald, A Patel, S C Body, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Transdermal modification of platelet function: an aspirin patch system results in marked suppression of platelet cyclooxygenaseB McAdam, R M Keimowitz, M Maher, et al.
Pageof 28

Showing results (91-100 of 271) with videos related to

Sort By:
Pageof 28
Journal of Virology|September 1, 1984
Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugateP Seth, D J Fitzgerald, M C Willingham, et al.
Cell|February 1, 1983
Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosisD J FitzGerald, R Padmanabhan, I Pastan, et al.
British Medical Journal (Clinical Research Ed.)|May 14, 1983
Accuracy of indirect blood pressure measurement in the elderlyW G O'Callaghan, D J Fitzgerald, K O'Malley, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Selective cyclooxygenase-2 inhibition by nimesulide in manL Cullen, L Kelly, S O Connor, et al.
Cancer Research|July 15, 1988
Enhancement of the activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell linesR Pirker, D J FitzGerald, M C Willingham, et al.
The Journal of Biological Chemistry|November 25, 1990
Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosolM Ogata, V K Chaudhary, I Pastan, et al.
The Journal of Biological Chemistry|October 15, 1993
Mechanism of action of Pseudomonas exotoxin. Identification of a rate-limiting stepA G Zdanovsky, M Chiron, I Pastan, et al.
Circulation|August 1, 1993
Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesisR M Keimowitz, G Pulvermacher, G Mayo, et al.
Perfusion|August 6, 2009
The relationship between heparin level and activated clotting time in the adult cardiac surgery populationD J Fitzgerald, A Patel, S C Body, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Transdermal modification of platelet function: an aspirin patch system results in marked suppression of platelet cyclooxygenaseB McAdam, R M Keimowitz, M Maher, et al.
Pageof 28